Shailendra Mahajan

VC| Healthcare | Fund Raising

📍 Austin, Texas, United States🔄 Updated September 2026💼 18 investments📅 11 years investing🗓 Last invested Mar 2022
VC🌍 United States
18
Total investments
1
Early stage
3
Mid stage
4
Late stage
11y
Years active

Portfolio

11 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Mar 2022
TripleBlind has created the most complete and scalable solution for privacy enhancing computation. The TripleBlind solution is software-only and delivered via a simple API. It solves for a broad range of use cases, with current focus on healthcare and financial services. The company is backed by Accenture, General Catalyst and The Mayo Clinic. TripleBlind’s innovations build on well understood principles, such as federated learning and multi-party compute. Our innovations radically improve the practical use of privacy preserving technologies, by adding true scalability and faster processing, with support for all data and algorithm types. We support all cloud platforms and unlock the intellectual property value of data, while preserving privacy and ensuring compliance with all known data privacy and data residency standards, such as HIPAA and GDPR. TripleBlind compares favorably with existing methods of privacy preserving technology, such as homomorphic encryption, synthetic data and tokenization and has documented use cases for more than two dozen mission critical business problems.
Investor
Mar 2022
Oura is an award-winning, fast-growing startup that helps people get up close and personal with their health. The Oura Ring and Oura App provide daily insights into sleep, activity, stress, recovery and much more. By providing daily feedback and practical steps to inspire healthy lifestyles, weve helped millions of people improve their sleep, understand their bodies, and transform their health. We’re on a mission to empower every person to own their inner potential, and we’re seeking talented individuals to join us on our journey. JOIN THE OURA TEAM We are a multi-disciplinary team of over 100 experts in hardware engineering, software development, machine learning, bioscience, sleep, industrial and UX design, production, marketing and customer experience. We always strive to learn more and dig deeper into our research and analytics, to stay engaged and creative in everything we do. We are uncompromising in delivering value to our members and our partners across the globe.. Ouraring Inc. is headquartered in San Francisco, CA
Board Member
Mar 2022
Securra Health enables connected, continuous and collaborative early detection and chronic care management via a smart health platform powered by our proprietary actionable intelligence engine. Securra provides automated virtual care programs across multiple therapeutic categories by applying standards and evidence-based care guidelines to diverse data sets using our proprietary technology. The goal of Securra is to deliver contextual, actionable insights at the point of decision making to improve QACE( quality, access, cost, experience) in the healthcare ecosystem. Securra’s ‘Expert in a box’ solution recommends the best care pathways to meet patients exactly where they are in the disease progression. Securra Health is headquartered In New York, USA serving customers in Dubai, UAE and Chennai, India.
Board Observer
May 2019
Spire Health is the market leader in continuous respiration sensing and high-adherence, patient-friendly ambulatory monitoring. Our mission is to harness the power of algorithms and sensors to improve health outcomes by empowering patients and physicians with useful and actionable data. We currently work with partners across a range of health conditions, including chronic obstructive pulmonary disease (COPD), congestive heart failure, asthma, sleep disorders and anxiety.
Investor
Feb 2019
Eccrine Systems, Inc. is individualizing the prescription of medicine with a breakthrough platform for remote, non-invasive, and quantitative medication monitoring through sweat. This breakthrough technology enables providers to personalize pharmacotherapy across applications ranging from opioid compliance to precision dosing of narrow therapeutic index drugs in oncology and organ transplant.
Investor
Apr 2018
Profusa’s mission is to make our body’s chemistry easily accessible to improve health and wellness. We are dedicated to becoming a leader in the development of real-time biosensors that provide unprecedented insights into our overall health status. We are leading the development of a new generation of biointegrated sensors that empowers the individual with the ability to monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease. Our technology enables the development of bioengineered sensors that become one with the body to detect and continuously transmit actionable, medical-grade data for personal and medical use. Profusa’s first clinical offering, the Lumee Oxygen Platform™, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. It may be used in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores) that do not heal properly; and reconstructive surgery. Any questions? Please visit profusa.com or email us at info@profusa.com
tosense ( Acquired by Baxter) Board Observer
Jan 2018
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.
Board Observer
Aug 2017
LVL is a wearable sensor company with an integrated optical sensor that simultaneously measures the body's most critical bio signals - including hydration, heart rate, respiratory rate, oxygen and more. We're the creators of oneLVL - the world's first hydration monitor, and BSXinsight - the world's first wearable lactate threshold sensor.
Board Observer
Jun 2016
Moduware is a modular IoT platform. Through modularity, anyone can customize the functions of their devices. Through our Modcase, the world’s first modular smartphone case, and the Modpack, a standalone modular device, users can go modular anywhere from the familiarity of the smartphone to the comforts of home. Moduware is an open platform, meaning anyone can create modules using our Developer's Kit and we will help bring them to life on the Moduware Hardware App Store, the first of it's kind. Find out more at Moduware.com
Board Observer
Feb 2016
Focus groups have called UnaliWear “OnStar for People” because we provide discreet support for falls, medication reminders, and a guard against wandering in a classically-styled watch that features an easy-to-use speech interface rather than buttons. Unlike traditional medical alert products, we work wherever you are, 24x7 - and unlike Apple Watch or Samsung Gear, we don’t require a smart phone, because it's built in. The Kanega watch combines cellular, Wi-Fi, GPS, Bluetooth (for hearing aids and telemedicine devices), an accelerometer for automatic fall detection, and continuous speech with artificial intelligence in the cloud that learns the wearer's lifestyle to provide predictive, pre-emptive support (think like a "NEST for People"​).
Board Observer
Jan 2016
Evergaze develops seeBOOST®, a novel and proprietary electronic wearable medical device for improving the vision of persons coping with Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR). seeBOOST overcomes the significant drawbacks of all currently marketed vision assistive devices, whether head- or spectacle-mounted, handheld or implanted. seeBOOST successfully addresses these patients'​ primary need: to better see all day while undertaking a variety of normal-life tasks. The proprietary, vastly superior and cost effective technology empowers Evergaze to own the unserved and growing market for AMD and DR visual assistive devices. In the U.S. today, over 2.2 Million persons with AMD and at least 750,000 persons with DR could beneficially use seeBOOST. This market is growing due to the aging population and the increased prevalence of diabetes.
Experience · 21 entries
All (21)
Investments (18)
Board (12)
2025
Managing Director
Apr 2025
WaveCrest Securities is a boutique investment bank headquartered in Brentwood, TN specializing in capital raising, M&A, advisory and corporate finance services.
2023
Managing Director
Apr 2023
Helping Innovative, Deserving Companies Find the Right Funds to Achieve Their Ultimate Success New Harbor Venture Partners (NHVP) is a placement agent specializing in raising capital for venture-backed and private-equity backed healthcare, life science and environmental science companies. Our team is four senior executives with diverse expertise in investing and raising fund globally. Mark Bosland, NHVP’s founder and president, also founded and led the highly respected Rockport Venture Partners (RVP) for 16 years. After years of successfully fulfilling its vision of introducing the newly established European venture community to exceptional US life sciences companies, the firm expanded to become a global placement agent. RVP ultimately closed more than 47 transactions and raised more than $600 million from venture, private equity, cross-over and hedge funds, as well as from structured finance firms and family offices. NHVP was launched to continue connecting these industry-focused investors with the most progressive, forward-looking client entrepreneurs and companies for their mutual benefit. At NHVP, we take a practical and realistic approach to raising capital backed by honesty, commitment and decades of experience. We work with management teams and boards of directors who understand that NOT all capital is equal, and finding the correct financial partner(s) is a financing goal. When entrepreneurs need next-level funding, NHVP draws on its proven network of industry-focused investors to ensure they meet this goal. NHVP specializes in institutional and strategic corporate financing for early- to growth-stage companies in the following industries: Healthcare / Life Science: * Biotech * Digital Health * Healthcare IT * Medical Devices * Pharmaceuticals * Tech-enabled Services * Therapeutics Environmental Science: * Ag Tech * Waste Conversion * Water Treatment Our goal for our clients is straightforward: to close a successful financing.
2022
Investor
Mar 2022
Nuvo is a healthcare technology leader advancing prenatal care with INVU by Nuvo™️, an FDA and CE-approved, AI-driven remote monitoring platform. INVU™️ seamlessly collects vital maternal and fetal biometric data, including fetal heart rate (FHR), maternal heart rate (MHR), and uterine activity. INVU, recognized among TIMEs Best Inventions of 2024, has earned acclaim for its transformative impact on maternal-fetal health monitoring. For clinicians, INVU enables the expansion of care services by offering remote fetal non-stress tests (NSTs). Healthcare providers benefit from streamlined clinical workflows, improved protocol adherence, and the ability to monitor multiple remote NSTs simultaneously. The platform enhances operational efficiency while creating new revenue opportunities and elevating practice prestige. For expecting mothers, this innovation allows them to do NSTs from home or work, eliminating travel time, waiting room delays, and childcare challenges. INVU gets outstanding reviews from expecting mothers that use it and has been shown to save as much as 12 hours for expecting mothers over the course of a pregnancy. INVU by Nuvo combines a comfortable wearable sensor band with sophisticated cloud-based processing and dedicated software applications for both mothers and physicians. The platform excels in monitoring high-risk pregnancies that are medically indicated for frequent monitoring, including cases involving hypertension, gestational diabetes, preeclampsia, high BMI, and advanced maternal age. The platforms remote monitoring capabilities expand access to quality prenatal care, particularly benefiting underserved communities. The data generated by INVU provides deeper insights into pregnancy health than has been possible before. Nuvo is leveraging AI to explore how INVU can help clinicians identify and address complications such as placental insufficiency, intrauterine growth restriction (IUGR), and fetal distress at earlier stages.
Investor
Mar 2022
TripleBlind has created the most complete and scalable solution for privacy enhancing computation. The TripleBlind solution is software-only and delivered via a simple API. It solves for a broad range of use cases, with current focus on healthcare and financial services. The company is backed by Accenture, General Catalyst and The Mayo Clinic. TripleBlind’s innovations build on well understood principles, such as federated learning and multi-party compute. Our innovations radically improve the practical use of privacy preserving technologies, by adding true scalability and faster processing, with support for all data and algorithm types. We support all cloud platforms and unlock the intellectual property value of data, while preserving privacy and ensuring compliance with all known data privacy and data residency standards, such as HIPAA and GDPR. TripleBlind compares favorably with existing methods of privacy preserving technology, such as homomorphic encryption, synthetic data and tokenization and has documented use cases for more than two dozen mission critical business problems.
Investor
Mar 2022
Oura is an award-winning, fast-growing startup that helps people get up close and personal with their health. The Oura Ring and Oura App provide daily insights into sleep, activity, stress, recovery and much more. By providing daily feedback and practical steps to inspire healthy lifestyles, weve helped millions of people improve their sleep, understand their bodies, and transform their health. We’re on a mission to empower every person to own their inner potential, and we’re seeking talented individuals to join us on our journey. JOIN THE OURA TEAM We are a multi-disciplinary team of over 100 experts in hardware engineering, software development, machine learning, bioscience, sleep, industrial and UX design, production, marketing and customer experience. We always strive to learn more and dig deeper into our research and analytics, to stay engaged and creative in everything we do. We are uncompromising in delivering value to our members and our partners across the globe.. Ouraring Inc. is headquartered in San Francisco, CA
Show all 21 entries ↓
Investment activity
2015–2022 · 18 investments
201532016420172201832019220224
Recent (last 2 years)Earlier